转录因子及其活性药理学纠正的方法
Svetlana V Guryanova1,2, Tatiana V Maksimova2, Madina M Azova2
1M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
International journal of molecular sciences
|July 12, 2025
概括
转录因子 (TFs) 对基因表达和细胞功能至关重要. 尽管药物开发面临挑战,但正在出现新的战略,以针对TF治疗癌症等疾病.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 转录因子 (TFs) 调节基因表达,对细胞过程至关重要.
- 失调的TF与癌症,自身免疫性疾病和神经退行等疾病有关.
- 历史上被认为是无法治疗的,TF现在是新型治疗干预措施的目标.
研究的目的:
- 审查目前用于调节转录因子活性的药理学策略.
- 突出重点转录因子家族及其在疾病中的作用.
- 讨论TF向疗法的挑战和未来方向.
主要方法:
- 对现有转录因子生物学和药理学文献的综述.
- 对主要转录因子家族 (NF-κB,p53,STATs,HIF-1α,AP-1,Nrf2) 的分析及其治疗向.
- 药理学策略的分类,包括抑制剂,激活剂,PROTAC和表观遗传调节剂.
主要成果:
- 几个TF家族 (NF-κB,p53,STATs,HIF-1α,AP-1,Nrf2) 与各种疾病有关,并具有特定的抑制剂或激活剂.
- 目前正在开发各种药理方法,包括小分子抑制剂,激活剂,PROTACs,分子和表观遗传修饰剂.
- 针对性TFs及其相关药物的例子包括NF-κB抑制剂,p53再激活剂 (Nutlin-3,APR-246),HIF-1α抑制剂/稳定剂 (acriflavine,roxadustat),STAT抑制剂 (JAK抑制剂,SD-36),AP-1抑制剂 (T-5224),以及Nrf2调节剂.
结论:
- 转录因子调制代表了许多疾病的有希望的治疗途径.
- 克服结构性难以接近,非目标效应和交付等挑战对于临床成功至关重要.
- 专注于特异性,安全性和高效交付的持续研究将释放TF向疗法的全部潜力.
关键词:
AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1这就是HIF-1α.在 NF-κBB 中.Nrf2 没有任何问题.这就是 PROTACs.美国国家统计数据 (STATs)表观遗传调节器 表观遗传调节器抑制抑制抑制的抑制作用分子粘剂分子粘剂在 p53 里,p53 是一个 p53 的代码.这是一个宽容的宽容度.相关概念视频
Transcription Factors
77.0K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
77.0K
General Transcription Factors
5.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.6K
Combinatorial Gene Control
8.4K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.4K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Co-activators and Co-repressors
7.6K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.6K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K


